NCT00651326 2023-08-04
DART
Canadian Cancer Trials Group
Phase 3 Terminated
Canadian Cancer Trials Group
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
National Cancer Institute (NCI)